Eun Kyoung Hong1,2,3, Zuhir Bodalal4,5, Federica Landolfi4,6, Nino Bogveradze4,7, Paula Bos4,5, Sae Jin Park8, Jeong Min Lee8, Regina Beets-Tan4,5. 1. Department of Radiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. amyh0803@gmail.com. 2. GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. amyh0803@gmail.com. 3. Seoul National University Hospital, Seoul, South Korea. amyh0803@gmail.com. 4. Department of Radiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. 5. GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. 6. Radiology Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy. 7. Academic Pridon Todua Medical Center, Research Institute of Clinical Medicine, Tbilisi, Georgia. 8. Seoul National University Hospital, Seoul, South Korea.
Abstract
PURPOSE: To assess the role of radiomics in detection of high-risk (pT3-4) colon cancer and develop a combined model that combines both radiomics and CT staging of colon cancer. METHODS: We included 292 colon cancer patients who underwent pre-operative CT and primary surgical resection within 2 months. Three-dimensional segmentations and CT staging of primary colon tumors were done. From each 3D segmentation of colon tumor, radiomic features were automatically extracted. Logistic regression analysis was performed to identify associations between radiomic features and high-risk (pT3-4) colon tumors. A combined model that integrated both radiomics and CT staging was developed and their diagnostic performance was compared with that of conventional CT staging. Tenfold cross-validation was used to validate the performance of the model and CT staging. RESULTS: The model that combined radiomic features and CT staging demonstrated a significantly better performance in detection of high-risk colon tumors in training set (AUC = 0.799, 95% CI: 0.720-0.839 for combined model and AUC = 0.697, 95% CI = 0.538-0.756 for CT staging only, p < 0.001 for difference). Cross-validation results also demonstrated significantly better detection performance of combined model (AUC = 0.727, 95% Confidence Interval (CI): 0.621-0.777 for combined model and AUC = 0.628, 95% CI = 0.558-0.689 for CT staging only, Boot CI = 0.099). CONCLUSION: CT radiomic features of primary colon cancer, combined with CT staging, can improve the detection of high-risk colon cancer patients.
PURPOSE: To assess the role of radiomics in detection of high-risk (pT3-4) colon cancer and develop a combined model that combines both radiomics and CT staging of colon cancer. METHODS: We included 292 colon cancer patients who underwent pre-operative CT and primary surgical resection within 2 months. Three-dimensional segmentations and CT staging of primary colon tumors were done. From each 3D segmentation of colon tumor, radiomic features were automatically extracted. Logistic regression analysis was performed to identify associations between radiomic features and high-risk (pT3-4) colon tumors. A combined model that integrated both radiomics and CT staging was developed and their diagnostic performance was compared with that of conventional CT staging. Tenfold cross-validation was used to validate the performance of the model and CT staging. RESULTS: The model that combined radiomic features and CT staging demonstrated a significantly better performance in detection of high-risk colon tumors in training set (AUC = 0.799, 95% CI: 0.720-0.839 for combined model and AUC = 0.697, 95% CI = 0.538-0.756 for CT staging only, p < 0.001 for difference). Cross-validation results also demonstrated significantly better detection performance of combined model (AUC = 0.727, 95% Confidence Interval (CI): 0.621-0.777 for combined model and AUC = 0.628, 95% CI = 0.558-0.689 for CT staging only, Boot CI = 0.099). CONCLUSION: CT radiomic features of primary colon cancer, combined with CT staging, can improve the detection of high-risk colon cancer patients.
Authors: Anders Jakobsen; Fahimeh Andersen; Anders Fischer; Lars H Jensen; Jens C R Jørgensen; Ole Larsen; Jan Lindebjerg; John Pløen; Søren R Rafaelsen; Jesper Vilandt Journal: Acta Oncol Date: 2015-04-29 Impact factor: 4.089
Authors: S Dighe; I Swift; L Magill; K Handley; R Gray; P Quirke; D Morton; M Seymour; B Warren; G Brown Journal: Colorectal Dis Date: 2012-04 Impact factor: 3.788
Authors: Elias Nerad; Max J Lahaye; Monique Maas; Patty Nelemans; Frans C H Bakers; Geerard L Beets; Regina G H Beets-Tan Journal: AJR Am J Roentgenol Date: 2016-08-04 Impact factor: 3.959
Authors: Lorenzo F Fanchi; Krijn K Dijkstra; José G Van den Berg; Emile E Voest; John B Haanen; Myriam Chalabi; Arend G Aalbers; Karolina Sikorska; Marta Lopez-Yurda; Cecile Grootscholten; Geerard L Beets; Petur Snaebjornsson; Monique Maas; Marjolijn Mertz; Vivien Veninga; Gergana Bounova; Annegien Broeks; Regina G Beets-Tan; Thomas R de Wijkerslooth; Anja U van Lent; Hendrik A Marsman; Elvira Nuijten; Niels F Kok; Maria Kuiper; Wieke H Verbeek; Marleen Kok; Monique E Van Leerdam; Ton N Schumacher Journal: Nat Med Date: 2020-04-06 Impact factor: 53.440
Authors: I van den Berg; S van de Weerd; J M L Roodhart; G R Vink; R R J Coebergh van den Braak; C R Jimenez; S G Elias; D van Vliet; M Koelink; E Hong; W M U van Grevenstein; M G H van Oijen; R G H Beets-Tan; J H J M van Krieken; J N M IJzermans; J P Medema; M Koopman Journal: BMC Cancer Date: 2020-08-18 Impact factor: 4.430